Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acthar in SLE with hematologic manifestations
NCT02779153Phase 4Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Oct 2016
- Primary completion
- May 2019
- Modality
- Peptides
01
Overview
A Phase 4 trial of corticotropin in systemic lupus erythematosus (SLE), sponsored by NYU Langone Health. Planned start Oct 2016; status: withdrawn.
02
Drugs
corticotropin
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02779153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02779153.